What is an emergency checklist for diagnosing and managing hyperosmolar hyperglycemic state, including glucose and serum osmolarity criteria, fluid resuscitation, potassium replacement, insulin titration, monitoring frequency, and precautions according to British Diabetes Society guidelines?

Emergency Clinical Reference Guide for Hyperosmolar Hyperglycemic State (HHS)

For HHS management, use the Joint British Diabetes Societies (JBDS) 2023 updated pathway as your primary framework, which emphasizes gradual osmolality correction (3-8 mOsm/kg/h), delayed insulin initiation until glucose stops falling with fluids alone, and aggressive fluid resuscitation targeting 50% deficit replacement within 12 hours. 1

DIAGNOSTIC CRITERIA

Confirm HHS when ALL of the following are present:

• Glucose ≥30 mmol/L (≥540 mg/dL) 1
• Calculated effective serum osmolality ≥320 mOsm/kg using formula: 2×Na+ + glucose (mmol/L) + urea (mmol/L) 1
  • Note: Effective osmolality >300 mOsm/L may be more sensitive diagnostically 2
• Ketonemia ≤3.0 mmol/L (minimal ketones) 1
• pH >7.3 (no significant acidosis) 1
• Bicarbonate ≥15 mmol/L 1
• Clinical features: Marked hypovolemia, altered mental status, severe dehydration 1

Critical caveat: 65.5% of HHS cases have concurrent DKA features, so don't exclude HHS diagnosis based solely on presence of ketones 2. Mixed presentations require modified management.

Initial Laboratory Assessment (STAT)

• Glucose, electrolytes (Na+, K+, Cl-), BUN, creatinine
• Calculate or measure serum osmolality
• Venous pH, bicarbonate, anion gap
• Ketones (blood preferred over urine)
• Complete blood count
• ECG
• Urinalysis, cultures as indicated 3

Calculate corrected sodium: For each 5.6 mmol/L (100 mg/dL) glucose above 5.6 mmol/L, add 1.6 mEq/L to measured sodium 3. This is critical—95.4% of HHS patients have hypernatremia when corrected sodium is used 2.

---

PHASE 0-1 HOUR: IMMEDIATE RESUSCITATION

Fluid Resuscitation Protocol

First Hour:

• 0.9% NaCl at 15-20 mL/kg/h (approximately 1-1.5 L in average adult) 3
• In severe hypovolemia, may repeat this bolus, but do not exceed 50 mL/kg over first 4 hours 3
• Estimated total fluid deficit: 100-220 mL/kg 1

Goal: Replace approximately 50% of estimated fluid deficit within first 12 hours 1, 4

Insulin Management - CRITICAL TIMING

DO NOT start insulin immediately. 1, 5

Withhold insulin until:

1. Glucose stops falling with IV fluids alone, AND
2. Osmolality has begun to decline with fluids 1, 5

Exception: If significant ketonemia present (>3.0 mmol/L), start insulin concurrently with fluids 1

When to start insulin:

• Fixed-rate IV insulin infusion: 0.05 units/kg/h 1
• If inadequate response, increase by 1.0 unit/h increments 1
• Alternative (ADA): 0.1 units/kg/h after 0.15 units/kg bolus 3

The JBDS lower rate (0.05 units/kg/h) is preferred over ADA's 0.1 units/kg/h to minimize rapid osmolality shifts 1, 6

Potassium Replacement - BEFORE INSULIN

Measure potassium immediately. Insulin administration depends on potassium level:

Serum K+	Action
<3.3 mmol/L	HOLD insulin. Give potassium replacement. Check K+ every 2 hours. Start insulin only when K+ ≥3.3 mmol/L [3,4]
3.3-5.0 mmol/L	Add 20-40 mEq/L potassium to each liter of IV fluid (2/3 KCl, 1/3 KPO4) [3]
>5.5 mmol/L	Withhold potassium. Recheck after starting fluids and insulin [3]

Target range during treatment: 4-5 mmol/L 4, 3

Critical warning: Hypokalemia occurs in ~50% during treatment and severe hypokalemia (<2.5 mEq/L) increases mortality 7. Monitor potassium every 2-4 hours initially.

---

PHASE 1-6 HOURS: ONGOING MANAGEMENT

Fluid Continuation

After initial resuscitation:

• Continue 0.9% NaCl as principal fluid 1, 5
• Rate adjusted to replace remaining deficit evenly over 48 hours total 3
• Generally 1.5 times 24-hour maintenance requirements achieves smooth rehydration 3

Sodium monitoring:

• Expect initial rise in measured sodium—this is normal and expected 5
• Rising measured sodium with falling corrected sodium indicates appropriate treatment 5
• Do NOT switch to hypotonic fluids based on rising measured sodium alone 5

Osmolality Monitoring - MOST CRITICAL PARAMETER

Target osmolality decline: 3-8 mOsm/kg/h 1

Absolute maximum: Do not exceed 3 mOsm/kg/h decline per ADA 3, though JBDS accepts up to 8 mOsm/kg/h 1

Why this matters: Rapid osmolality correction causes cerebral edema and central pontine myelinolysis 5, 3. This is the primary cause of treatment-related mortality.

Calculate osmolality every 2-4 hours 3, 4

Glucose Management

Target glucose in first 24 hours: 10-15 mmol/L (180-270 mg/dL) 1

When glucose reaches 14 mmol/L (250 mg/dL):

• Add 5-10% dextrose to IV fluids 1, 3
• Continue 0.9% NaCl alongside dextrose 1
• Reduce insulin infusion rate to 0.05-0.1 units/kg/h (3-6 units/h) 3

Expected glucose decline: 50-75 mg/dL/h 3

If glucose not falling by 50 mg/dL in first hour:

1. Verify adequate hydration
2. Double insulin infusion rate hourly until achieving target decline 3

---

PHASE 6-12 HOURS: STABILIZATION

Monitoring Frequency

Every 2-4 hours until stable: 3, 4

• Glucose
• Electrolytes (Na+, K+, Cl-)
• BUN, creatinine
• Calculated osmolality
• Venous pH (if mixed DKA/HHS)

Continuous monitoring:

• Urine output (target ≥0.5 mL/kg/h) 1
• Mental status
• Hemodynamic status
• Fluid balance

Adjusting Therapy

If osmolality declining too rapidly (>8 mOsm/kg/h):

• Slow IV fluid rate
• Consider reducing insulin rate
• Increase dextrose concentration if glucose <14 mmol/L

If osmolality not declining adequately (<3 mOsm/kg/h):

• Verify adequate fluid administration
• Check for unrecognized fluid losses
• Ensure insulin is running if indicated

---

PHASE 12-24 HOURS: CONTINUED CORRECTION

Continue same management principles with ongoing adjustments

Fluid goals by 24 hours:

• Clinical improvement evident
• Urine output ≥0.5 mL/kg/h
• Hemodynamic stability
• Mental status improving toward baseline

Metabolic goals by 24 hours:

• Glucose 10-15 mmol/L
• Osmolality declining steadily toward <300 mOsm/kg
• Potassium 4-5 mmol/L

---

PHASE 24-72 HOURS: RESOLUTION

Resolution Criteria (ALL must be met)

• Osmolality <300 mOsm/kg 1
• Hypovolemia corrected (urine output ≥0.5 mL/kg/h) 1
• Cognitive status returned to pre-morbid baseline 1
• Blood glucose <15 mmol/L 1

Transition to Subcutaneous Insulin

When patient able to eat and drink:

1. Calculate subcutaneous insulin dose from IV insulin requirements:

   • Total daily dose = 50% of total IV insulin given in last 24 hours 8
   • Give 50% as basal insulin (once daily long-acting)
   • Give 50% as prandial insulin (divided among 3 meals) 8

2. Timing is critical:

   • Give subcutaneous basal insulin
   • Continue IV insulin for 2-4 hours after subcutaneous dose 4
   • Then discontinue IV insulin

---

CRITICAL PRECAUTIONS TO AVOID COMPLICATIONS

Preventing Cerebral Edema/Central Pontine Myelinolysis

• Never exceed 8 mOsm/kg/h osmolality decline 1
• Avoid hypotonic fluids in first 12-24 hours 5
• Monitor neurological status continuously
• If mental status deteriorates during treatment, immediately slow fluid rate and obtain head CT

Preventing Fluid Overload

• High risk in elderly and those with cardiac/renal disease 3
• Monitor for pulmonary edema, peripheral edema
• Consider hemodynamic monitoring/central venous pressure in high-risk patients 4
• Adjust fluid rates based on clinical response, not just formulas

Preventing Hypokalemia

• Check potassium before every insulin dose adjustment
• Maintain aggressive potassium replacement throughout treatment
• Never allow K+ to fall below 3.3 mmol/L 3

Preventing Hypoglycemia

• Start dextrose infusion when glucose reaches 14 mmol/L 1
• Never stop insulin abruptly—adjust rate and add dextrose
• Continue monitoring glucose every 2-4 hours even after resolution

Thromboembolism Prophylaxis

• All HHS patients require VTE prophylaxis 1
• Use pharmacologic prophylaxis unless contraindicated
• Consider mechanical prophylaxis if bleeding risk high

---

SPECIAL CONSIDERATIONS

Mixed DKA/HHS (65.5% of cases) 2

• Start insulin immediately with fluids (don't delay)
• Target glucose 150-200 mg/dL for DKA component 4
• Monitor both osmolality AND pH/anion gap
• May require higher insulin rates

Elderly Patients

• More prone to fluid overload
• Higher risk of cerebral complications with rapid correction
• Consider slower fluid rates (aim for lower end of recommended range)
• More frequent monitoring required

Precipitating Causes - MUST IDENTIFY AND TREAT

• Infection (most common) 9
• Acute coronary syndrome
• Stroke
• Medication non-compliance
• New-onset diabetes
• Obtain cultures, chest X-ray, ECG as indicated 3

---

QUICK REFERENCE SUMMARY TABLE

Parameter	Target	Monitoring Frequency
Osmolality decline	3-8 mOsm/kg/h	Every 2-4 hours
Glucose (first 24h)	10-15 mmol/L	Every 2-4 hours
Potassium	4-5 mmol/L	Every 2-4 hours initially
Fluid replacement	50% deficit in 12h	Continuous assessment
Insulin rate (initial)	0.05 units/kg/h	Adjust hourly if needed
Urine output	≥0.5 mL/kg/h	Hourly

This protocol prioritizes patient safety through gradual correction of metabolic derangements while aggressively treating the underlying hypovolemia that defines HHS. The JBDS pathway 1 represents the most current evidence-based approach, refined from earlier guidelines 3 with specific attention to preventing iatrogenic complications from overly aggressive correction.